Cefdinir

Product NDC: 68071-3156
Requested package NDC: 68071-3156-6
11-digit product format: 680713156
Labeler code: 68071
Product ID: 68071-3156_2d53fd8c-5f3f-8b3f-e063-6394a90a3ea0
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Cefdinir
Dosage form: POWDER, FOR SUSPENSION
Route: ORAL
Labeler: NuCare Pharmaceuticals, Inc.
Application: ANDA065332
Marketing category: ANDA
Marketing start: 2007-05-08
Substance: CEFDINIR MONOHYDRATE
Active strength: 125 mg/5mL
Pharmacologic classes: Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 3 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Product NDC	Package NDC	Code	Status	Archive	Snapshot	Source SHA-256
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	68071-3156	68071-3156-6	U	Excluded because listing certification expired	excluded / ndc_excluded.zip	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	68071-3156	68071-3156-6	U	Excluded because listing certification expired	excluded / ndc_excluded.zip	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	68071-3156	68071-3156-6	U	Excluded because listing certification expired	excluded / ndc_excluded.zip	`0efc9e666f02…`	`f202fb6c5f17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A065332-001	CEFDINIR	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB		2007-05-04
A065332-002	CEFDINIR	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB		2007-05-04

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A065332-001	AB
A065332-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A065332-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065332-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065332-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065332-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065332-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065332-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065332-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065332-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065332-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065332-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065332-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065332-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065332-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065332-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065332-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065332-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065332-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065332-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065332-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065332-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065332-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065332-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065332-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065332-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065332-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065332-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065332-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A065332-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065332-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065332-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065332-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A065332-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065332-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A065332-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065332-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A065332-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065332-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A065332-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A065332-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A065332-002	AB	1	`782e0a99824c…`

Additional Listing Data#

Finished product: Yes
Brand name base: Cefdinir
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
CEFDINIR MONOHYDRATE	125 mg/5mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
6E7SN358SE	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
309054	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
4ade94bb-6c39-13cd-e054-00144ff8d46c	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d3e72f63-2c41-955f-f4ce-e90c6403e67c	Product name	2	20210729
e8e66e64-d220-99cb-44eb-0f32dc8cbda1	Product name	2	20210729

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
68071-3156-6	2025-02-04	C162847	48780-1	2cef2736-6bf7-d83d-e063-dadaa90ab31f	CEFDINIR FOR ORAL SUSPENSION USP 4136 4137 Rx only
68071-3156-6	2025-01-30	C162847	48780-1	2cef2736-6bf7-d83d-e063-dadaa90ab31f	CEFDINIR FOR ORAL SUSPENSION USP 4136 4137 Rx only

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
68071-3156-6	Cefdinir	60 mL in 1 BOTTLE	POWDER, FOR SUSPENSION	60		6

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68071-3156	CEFDINIR POWDER, FOR SUSPENSION [NUCARE PHARMACEUTICALS, INC.]	6	Current NDC, Legacy NDC, 1 package rows	20250206_4ade94bb-6c39-13cd-e054-00144ff8d46c.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 5 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Cefdinir	CEFDINIR	Preferred Pharmaceuticals Inc.	0d1212c9-604f-4999-8f7d-e7cf300705ef	2026-03-24	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065332 application number: ANDA065332
Cefdinir	CEFDINIR	A-S Medication Solutions	1d58b10c-b253-4925-8681-580aa2e8ae2e	2025-08-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065332 application number: ANDA065332
Cefdinir	CEFDINIR	NuCare Pharmaceuticals, Inc.	4ade94bb-6c39-13cd-e054-00144ff8d46c	2025-02-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065332 application number: ANDA065332 ndc (package): 68071-3156-6 ndc (product): 68071-3156 ndc11 (package): 68071315606
Cefdinir	CEFDINIR	Teva Pharmaceuticals USA, Inc.	a1f49fe1-b511-4f6b-a912-8ae8662d95a5	2023-02-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065332 application number: ANDA065332
Cefdinir	CEFDINIR	Proficient Rx LP	f22acd90-5dc4-406d-af78-5f9c3a674647	2022-03-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065332 application number: ANDA065332

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
6E7SN358SE	CEFDINIR MONOHYDRATE	213978-34-8	CEFDINIR MONOHYDRATE
CI0FAO63WC	CEFDINIR	91832-40-5	Cefdinir

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
309054	cefdinir 125 MG in 5 mL Oral Suspension	PSN	4ade94bb-6c39-13cd-e054-00144ff8d46c	6
309054	cefdinir 25 MG/ML Oral Suspension	SCD	4ade94bb-6c39-13cd-e054-00144ff8d46c	6
309054	cefdinir 125 MG per 5 ML Oral Suspension	SY	4ade94bb-6c39-13cd-e054-00144ff8d46c	6

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
68071-3156-6	68071315606	60 mL in 1 BOTTLE (68071-3156-6)	60 ml	2017-03-16	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
CEFDINIR FOR ORAL SUSPENSION USP 4136 4137 Rx only	NuCare Pharmaceuticals, Inc.	2025-02-04	HUMAN PRESCRIPTION DRUG LABEL	6